Congress Must Take Action To Support Antibiotic R&D

The Hill: Discovery of new superbug gene underscores the need for Congress to act now
Johan Bakken, president of the Infectious Diseases Society of America

“…[A]ntibiotic research and development (R&D) continues to lag behind existing patient needs and upcoming threats. Fortunately, Congress can help combat the threat of these deadly infections, but we must act now. First, Congress can pass funding legislation that provides the increases requested by the president for the Centers for Disease Control and Prevention (CDC), National Institute for Allergy and Infectious Diseases (NIAID), Biomedical Advanced Research and Development Authority (BARDA), Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA). … Second, Congress can provide urgently needed new incentives to stimulate the development of antibiotics to treat superbugs. … Lastly, Congress can address the regulatory barriers to antibiotic R&D…” (11/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.